Discontinuing Disease Modifying Therapy in Progressive Multiple Sclerosis - Can We Stop What We Have Started?

被引：0
|
作者：
Lonergan, Roisin
Kinsella, Katie
Duggan, Marguerite
Jordan, Sinead
Bradley, David
Hutchinson, Michael
Tubridy, Niall
机构：
来源：
NEUROLOGY | 2010年 / 74卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：A547 / A547
页数：1
相关论文
共 50 条
  • [41] Can We Stop Reflexively Discontinuing Mineralocorticoid Antagonists for Patients With Heart Failure and Hyperkalemia?
    Mastoris, Ioannis
    Van Spall, Harriette G. C.
    Sauer, Andrew J.
    JOURNAL OF CARDIAC FAILURE, 2022, 28 (09) : 1464 - 1468
  • [42] What we have done so far and what we can achieve (II)
    Morais, A.
    REVISTA PORTUGUESA DE PNEUMOLOGIA, 2015, 21 (02) : 51 - 52
  • [43] Plastic pollution: What have we done? What more can we do?
    Yu, Haoxuan
    Deng, Zixuan
    Zahidi, Izni
    Fai, Chow Ming
    Liang, Dongfang
    Madsen, Dag Oivind
    ECOTOXICOLOGY AND ENVIRONMENTAL SAFETY, 2024, 286
  • [44] Disease-Modifying Treatment in Progressive Multiple Sclerosis
    Ciotti, John Robert
    Cross, Anne Haney
    CURRENT TREATMENT OPTIONS IN NEUROLOGY, 2018, 20 (05)
  • [45] Disease-Modifying Treatment in Progressive Multiple Sclerosis
    John Robert Ciotti
    Anne Haney Cross
    Current Treatment Options in Neurology, 2018, 20
  • [46] Disease-modifying treatments for progressive multiple sclerosis
    Comi, Giancarlo
    MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (11) : 1428 - 1436
  • [47] Multiple RRTs: How Can We Stop Them?
    Hilewitz, A.
    Tsegaye, A.
    Lee, B.
    Lazo, K.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [48] What do we want, what do we have, what can we do? (unfolding in LHC era)
    Anikeev, VB
    NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION A-ACCELERATORS SPECTROMETERS DETECTORS AND ASSOCIATED EQUIPMENT, 2003, 502 (2-3): : 792 - 794
  • [49] Can we predict the evolution of an unpredictable disease like multiple sclerosis?
    Bergamaschi, R.
    EUROPEAN JOURNAL OF NEUROLOGY, 2013, 20 (07) : 995 - 996
  • [50] What can we learn from failed clinical trials in multiple sclerosis?
    Tjalf Ziemssen
    Journal of Neurology, 2008, 255 : 97 - 101
12345